[Form 4] Mobiquity Technologies, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Dr. Gene Salkind, a director and 10% owner of Mobiquity Technologies, Inc. (MOBQ), purchased equity and converted instruments on 09/15/2025. The filing shows a purchase of 25,000 shares of common stock at $1.00 and the acquisition of 100,000 shares via a $1.00 convertible note executed the same day. After these transactions, Dr. Salkind directly owns 8,668,695 common shares and beneficially owns 511,544 shares attributable to derivative securities and other instruments held by him, his wife and a family trust. The filing also lists warrants and options underlying a portion of those beneficial holdings.

Positive

• Insider purchase of 25,000 common shares at $1.00, signaling a direct acquisition of equity
• Conversion/acquisition of 100,000 shares via a $1.00 convertible note on the same date
• Transparency: Form 4 discloses direct holdings and related-party attribution (wife and family trust)

Negative

• Potential dilution: 511,544 shares are attributable to the reporting person through warrants, options and the convertible note
• High exercise prices on some warrants/options (e.g., $60.00 and $68.48) indicate portion of instruments may be effectively out-of-the-money
• Concentrated ownership: Large direct holding (8,668,695 shares) increases insider voting influence

Insights

Financial Analyst

TL;DR: Insider increased direct equity stake via a low-priced purchase and convertible note, modestly concentrating ownership.

The reported 25,000 share purchase at $1.00 and the 100,000-share convertible-note acquisition increase Dr. Salkind's direct and attributed holdings, bringing direct ownership to 8,668,695 shares. The filing quantifies additional potential dilution from warrants and options totaling 511,544 shares attributed to the reporting person and related parties. For investors, the transaction is a straightforward insider buy and conversion, but the existence of multiple in-the-money and out-of-the-money derivative instruments means outstanding dilution should be modeled when assessing stake and voting power.

Corporate Governance Expert

TL;DR: Director and 10% owner executed purchases and a note conversion; related-party holdings are disclosed, consistent with Section 16 reporting.

The Form 4 discloses direct ownership and related-party attribution (spouse and family trust), which is important for transparency. The mix of direct shares, warrants, options and a convertible note creates layered rights and potential future transfers of economic interest. Disclosure appears complete for the reported transactions and the nature of indirect ownership is specified, aiding shareholder oversight of insider concentration and potential dilution.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Salkind Gene

(Last) (First) (Middle)

35 TORRINGTON LANE

(Street)

SHOREHAM NY 11766

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Mobiquity Technologies, Inc. [ MOBQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	09/15/2025		A		25,000	A	$1	8,668,695(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible notes(2)	$1	09/15/2025		A		100,000		09/15/2025	10/17/2025	Common Stock	100,000	(3)	511,544(4)	D

Explanation of Responses:

1. Represents interest paid on a convertible note

2. The securities listed in Table I and Table II are securities owned directly by Dr. Salkind and his wife and by a family trust.

3. Not applicable.

4. Includes (i) 59,211 shares underlying warrants exercisable at $60 per share, (ii) 2,333 shares underlying options exercisable at $68.48 per share, (iii) 100,000 shares underlying options exercisable at $.20 per share, (iv)100,000 shares underlying a convertible note at $1.00 per share and (v) options to purchase 250,000 shares exercisable at $2.45 per share.

	/s/ Gene Salkind	09/17/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Gene Salkind report on Form 4 for MOBQW?

The Form 4 reports a 25,000-share purchase at $1.00 and acquisition of 100,000 shares via a $1.00 convertible note on 09/15/2025, with related-party attribution noted.

How many shares does Gene Salkind directly own after the transactions?

The filing states Dr. Salkind directly owns 8,668,695 common shares following the reported transactions.

What derivative or contingent securities are attributed to Salkind?

The filing attributes 511,544 shares to Salkind from warrants, options and a convertible note, including specified instruments exercisable at $60.00, $68.48, $0.20, $1.00 and $2.45 per share.

Are any related parties included in the reported beneficial ownership?

Yes. The securities listed are owned directly by Dr. Salkind, his wife and by a family trust, as disclosed in the explanation.

When were these transactions executed?

All reported transactions were executed on 09/15/2025, and the Form 4 was signed on 09/17/2025.